Abbott,K.“The 1904 Olympic Marathon May Have Been the Strangest Ever.”Smithsonian,August 7,2012.
Abraham,E.“Howard Walter Florey,Baron Florey of Adelaide and Marston,1898–1968.”Biographical Memoirs of Fellows of the Royal Society 17(November 1971):255–302.
Abraham,E.“Ernst Boris Chain:19 June 1906–12 August 1979.”Biographical Memoirs of Fellows of the Royal Society 29(November 1983):42–91.
Afflitto,E.Penicillin,Venereal Disease,and the Relationship Between Science and the State in America,1930–1950. Ann Arbor,MI:University Microfilms/ProQuest,May 2012.
Allan,N.“We’re Running Out of Antibiotics.”Atlantic,March 2014,34.
American Chemical Society.“Merck Laboratory Dedication.”Chemical Engineering News 11,no.9(May 10,1933):137.
American Chemical Society.“Selman Waksman and Antibiotics.National Historic Chemical Landmarks.”American Chemical Society(2005).Retrieved June 5,2014.www.acs.org/content/acs/en/education/whatis chemistry/landmarks/selmanwaksman.html.
An American Physician.The Eclectic and General Dispensatory. Philadelphia:Towar and Hogan,1827.
Barnett,J.A.“Beginnings of Microbiology and Biochemistry:The Contribution of Yeast Research.”Microbiology 149,no.3(March 2003):557–67.
Bean,W.B.“Vitamania,Polypharmacy,and Witchcraft.”Archives of Internal Medicine 96,no.2(August 1,1955):137–41.
Belofsky,N.Strange Medicine:A Shocking History of Medical Practice Through the Ages. New York:Penguin,2013.
Berg,A.The Nutrition Factor:Its Role in National Development. Washington,DC:Brookings Institution Press,1973.
Bhatt,A.“Evolution of Clinical Research:A History Before and Beyond James Lind.”Perspectives in Clinical Research 1,no.1(January–March 2010):6–10.
Blair,J.C.Seeds of Destruction:A Study in the Functional Weaknesses of Capitalism. New York:Covici Friede,1938.
Blaser,M.J.Missing Microbes:How the Overuse of Antibiotics Is Fueling Our Modern Plagues. New York:Picador,2015.
Blout,E.Robert Burns Woodward:1917–1979.Biographical Memoirs, Vol.80.Washington,DC:National Academy Press,2001.
Bosch,F.,et al.“The Contributions of Paul Ehrlich to Pharmacology:A Tribute on the Occasion of the Centenary of His Nobel Prize.”Pharmacology,82,no.3(October 2008):171–79.
Bowden,M.E.Robert Burns Woodward and the Art of Organic Synthesis.Philadelphia:Chemical Heritage Press,1992.
Bratbak,G.“Bacterial Biovolume and Biomass Estimations.”Applied and Environmental Microbiology 49,no.6(June 1985):1488–93.
Brody,H.Hooked:Ethics,the Medical Profession,and the Pharmaceutical Industry. Lanham,MD:Rowman ＆ Littlefield,2007.
Bud,R.“Antibiotics,Big Business,and Consumers:The Context of Government Investigations into the Postwar American Drug Industry.”Technology and Culture 46,no.2(April 2005):329–49.
Bud,R.Penicillin:Triumph and Tragedy. Oxford:Oxford University Press,2007.
Bud,R.“Upheaval in the Moral Economy of Science:Patenting,Teamwork,and the World War II Experience of Penicillin.”History and Technology:An International Journal 24,no.2(March 7,2008):173–90.
Bud,R.“Innovators,Deep Fermentation,and Antibiotics.”Dynamis 31,no.2(2011):323–41.
Bunch,R.L.Erythromycin,its salts,and method of preparation.U.S.Patent No.US 2653899 A,filed April 14,1952,and issued September 29,1953.
Burkholder,P.R.“Studies on the Antibiotic Activity of Actinomycetes.”Journal of Bacteriology 52,no.4(October 1946):503–4.
Byck,R.The Cocaine Papers of Sigmund Freud. Edited and with an
introduction by Robert Byck.New York:Stonehill,1974.
Byrne,J.P.Encyclopedia of Pestilence,Pandemics,and Plagues, Vol.1,A–M.Westport,CT:Greenwood Press,2008.
Cantrill,S.“The Greatest Chemist of All Time?”Nature Chemist(January 7,2011).
Carpenter,D.Reputation and Power:Organizational Image and Pharmaceutical Regulation at the FDA. Princeton,NJ:Princeton University Press,2010.
Chain,E.,et al.“Penicillin as a Chemotherapeutic Agent.”Lancet 236,no.6104(August 24,1940):226–28.
Chalke,H.“The Impact of Tuberculosis on History,Literature,and Art.”Medical History 6,no.4(October 1962):301–18.
Chandler,A.D.Shaping the Industrial Century:The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries.Cambridge,MA:Harvard University Press,2005.
Chicago Tribune.“Girl,20,Dead After Refusal of Penicillin;Had 19 Transfusions for Blood Disease.”Chicago Tribune,August 26,1943.
Churchill,W.“We Shall Fight on the Beaches.”Great Speeches of the Twentieth Century.The Guardian,April 20,2002.
CIBA.Man and His Future:A CIBA Foundation Volume. Edited by Gordon Wolstenholme.Boston:Little,Brown,1963.
Clardy,J.F.“The Natural History of Antibiotics.”Current Biology 19,no.11(June 2009):437–41.
Clark,R.The Life of Ernst Chain:Penicillin and Beyond. London:Bloomsbury,1985.
Clarke,H.J.The Chemistry of Penicillin. Princeton,NJ:Princeton University Press,1949.
Coghill,R.,et al.Method for Increased Yields of Pencillin.U.S.Patent No.2423873 A,June 17,1944.
Colebrook,L.“Almroth Edward Wright:1861–1947.”Obituary Notices of Fellows of the Royal Society 6,no.17(November 1948):297–314.
Colebrook,L.“Gerhard Domagk.”Biographical Memoirs of Fellows of the Royal Society 10(November 1964):39.
Comas,I.,et al.“Out-of-Africa Migration and Neolithic Co-Expansion of Mycobacterium tuberculosis with Modern Humans.Nature:Genetics 45,no.10(October 2013):1176–82.
Committee on Statistics.Steel Statistical Yearbook. Brussels:International Iron ＆ Steel Institute,1981.
Congressional Quarterly.“Subcommittee Investigates Drug Prices.”CQ Almanac 1960, 16th ed.Washington,DC:Congressional Quarterly,1960,11-743–49.
Cope,O.M.“The Treatment of the Surface Burns.”Annals of Surgery 117,no.6(June 1943):885–93.
Council on Drugs.“Blood Dyscrasias Associated with Chloramphenicol(Chloromycetin) Therapy.”Journal of the American Medical Association 172,no.18(April 30,1960):2044–45.
Crivellato,E.,et al.“Paul Ehrlich’s Doctoral Thesis:A Milestone in the Study of Mast Cells.”British Journal of Hematology 123(2003):19–21.
Daemmrich,A.Pharmacopolitics:Drug Regulation in the United States and Germany. Philadelphia:Chemical Heritage Foundation,2004.
Daniel,T.M.Pioneers in Medicine and Their Impact on Tuberculosis.Rochester,NY:University of Rochester Press,2001.
Dauer,C.,et al.“Mortality from Influenza,1957–1958 and 1959–1960.”American Review of Respiratory Diseases 83(1961):15–28.
Davies,J.“Antibiotic Resistance and the Future of Antibiotics.”In D.A.Relman,Microbial Evolution and Co-Adaptation:A Tribute to the Life and Scientific Legacies of Joshua Lederberg.Washington,DC:National Academies Press,2009,158–92.
de Costa,C.,et al.“American Resurrection and the 1788 New York Doctors’Riot.”Lancet 377,no.9762(January 2011):22–28.
Dever,L.A.“Mechanisms of Bacterial Resistance to Antibiotics.”Archives of Internal Medicine 151,no.5(May 1991):886–95.
DiMasi,J.H.“The Price of Innovation:New Estimates of Drug Development Costs.”Journal of Health Economics 22,no.2(March 2003):151–85.
Dodson,G.“Dorothy Mary Crowfoot Hodgkin,O.M.,23 May 1910–29 July 1994.”Biographical Memoirs of the Fellows of the Royal Society 48(December 1,2002):179–219.
Doll,R.“Austin Bradford Hill,8 July 1897–18 April 1991.”Biographical Memoirs of the Fellows of the Royal Society 40(November 1994):128–40.Douglas,S.“Georges Dreyer:1873–1934.”Obituary Notices of Fellows of the Royal Society 1,no.4(December 1935):568–76.
Duggar,B.“Aureomycin:A Product of the Continuing Search for New Antibiotics.”Annals of the New York Academy of Sciences 51(November 1948):177–81.
Dunhill,M.The Plato of Praed Street:The Life and Times of Almroth Wright.London:RSM Press,2000.
Ellis,J.J.His Excellency,George Washington. New York:Vintage,2005.
Federal Trade Commission.Federal Trade Commission Economic Report on Antibiotics Manufacture. Washington,DC:U.S.Government Printing Office,1958.
Ferry,G.Dorothy Hodgkin:A Life. London:Granta Books,1998.
Finland,M.J.“Occurrence of Serious Bacterial Infections Since Introduction of Antibacterial Agents.”Journal of the American Medical Association 170,no.18(August 1959):2188–97.
Finlay,M.R.“The Industrial Utilization of Farm Products and By-Products:The USDA Regional Research Laboratories.”Agricultural History 64,no.2(Spring 1990):41–52.
Finney,J.“Senate Panel Cites Mark-Ups on Drugs Ranging to 7,079%.”New York Times,December 8,1959,1.
Fisher,M.W.“The Susceptibility of Staphylococci to Chloramphenicol.”Archives of Internal Medicine 105,no.3(March 1960):412–23.
Fisher,R.The Genetical Theory of Natural Selection. Oxford:Clarendon Press,
1930.
Fitzgerald,J.“Louis Pasteur:His Contribution to Anthrax Vaccination and the Evolution of a Principle of Active Immunization.”California State Journal of Medicine 21,no.3(March 1923):101–3.
Flavell-White,C.“Pfizer’s Penicillin Pioneers.”TCE Today(February 2010):54–55.
Fleming,A.“Some Notes on the Bacteriology of Gas Gangrene.”Lancet 186,no.4799(August 1915):376–78.
Fleming,A.“On the Antibacterial Action of Cultures of a Penicillium,with Special Reference to Their Use in the Isolation of B.influenzae.The British Journal of Experimental Pathology 10(May 1929):226–36.
Fleming,A.“Penicillin.”Nobel Lecture.December 11,1945.NobelPrize.org.Retrieved November 1,2014.www.nobelprize.org/nobel_prizes /medicine/laureates/1945/fleming-lecture.pdf.
Florey,H.Interview by H.de Berg.Tape recording.April 16,1967.National Library,Canberra.
Folkers,K.A.Interview with Karl August Folkers.By L.Gortler.July 6,1990.Philadelphia:Chemical Heritage Society.
Forman,S.The Life and Writings of Thomas Jefferson,Including All of His Important Utterances on Public Questions,Compiled from State Papers and His Private Correspondence. Indianapolis:Bobbs-Merrill Company,1900.
Frith,J.“Syphilis:Its Early History and Treatment until Penicillin and the Debate on Its Origins.”Journal of Military and Veteran’s Health 20,no.4(2012).
Galdston,I.Behind the Sulfa Drugs:A Short History of Chemotherapy. New York:Appleton-Century,1943.
Gaskins,H.,et al.“Antibiotics as Growth Promotants:Mode of Action.”Animal Biotechnology 13,no.1(2002):29–42.
Geison,G.L.The Private Science of Louis Pasteur. Princeton,NJ:Princeton University Press,1995.
Godlee,S.R.Lord Lister. London:Macmillan,1918.
Gortler,L.“Merck in America:The First 70 Years from Fine Chemicals to Pharmaceutical Giant.”Bulletin for the History of Chemistry 25,no.1(2000):1–9.
Gradmann,C.“Robert Koch and the Pressures of Scientific Research:Tuberculosis and Tuberculin.”Medical History 45(2001):1–32.
Graham,J.P.“Growth Promoting Antibiotics in Food Animal Production:An Economic Analysis.”Public Health Reports 122,no.1(January–February 2007):79–87.
Grayson,M.B.“Henry Welch,FDA,and the Origins of ICAAC.”Microbe 5,no.9(September 2010):382.
Greene,J.A.“Reform,Regulation,and Pharmaceuticals —The KefauverHarris Amendments at 50.”New England Journal of Medicine 167(October 18,2012):1481–83.
Greenwood,D.Antimicrobial Drugs:Chronicle of a Twentieth Century
Medical Triumph.New York:Oxford University Press,2008.
Grinnell.“Doctors Get a Heap of Comfort from Grinnell Gloves.”Advertisement.Journal of the American Medical Association 63(October–November 1914):31.
Grizzard,F.E.George Washington:A Biographical Companion. Santa Barbara,CA:ABC-CLIO,2002.
Hager,T.The Demon Under the Microscope:From Battlefield Hospitals to Nazi Labs,One Doctor’s Heroic Search for the World’s First Miracle Drug.
New York:Harmony Books,2006.
Hayes,J.“Notes on Forensic Medicine:Smell.”The Graveyard Shift(2008).Retrieved January 22,2013.www.leelofland.com/wordpress/jonathanhayes-notes-on-forensic-medicine-smell/.
Hayes,P.“Carl Bosch and Carl Krauch:Chemistry and the Political Economy of Germany 1025–1945.”The Journal of Economic History 47,no.2(June 1987):353–63.
Heaman,E.St.Mary’s:The History of a London Teaching Hospital.London:Longmans,2004.
Heatley,N.B.“A New Type of Microrespirometer.”Journal of Biochemistry 33,no.1(January 1939):53–67.
Hebert,M.“Who Killed George Washington?”Medical Gumbo(February 16,2009).Retrieved August 17,2014.open.salon.com/blog/michael_hebert/2009/02/16/what_killed_george_washington.
Hobby,G.Penicillin:Meeting the Challenge. New Haven,CT:Yale University
Press,1985.
Hoeffle,M.L.“The Early History of Parke-Davis and Company.”Bulletin of the History of Chemistry 25,no.1(2000):25–32.
Holmberg,A.,et al.“Les Prix Nobel en 1945.”Stockholm:The Nobel Foundation,1946.
Holmes,O.W.“On the Contagiousness of Puerperal Fever.”New England Quarterly Journal of Medicine 1(1843):503–30.
Holmes,O.W.The Writings of Oliver Wendell Holmes, Vol.9.Boston:Houghton Mifflin,1899.
Houting,B.A.“Did George Washington’s Doctors Hasten His Death?”Constitution Daily,August 30,2011.
Hughes,H.W.Alexander Fleming and Penicillin. London:Priory Press,1979.Jacobs,W.A.(1924).“Certain Aspects of the Chemotherapy of Protozoan and Bacterial Infections.”Medicine 3,no.2(1924):165–93.
Janik,E.Marketplace of the Marvelous:The Strange Origins of Modern Medicine. Boston:Beacon Press,2014.
Johnson,S.Where Good Ideas Come From:The Natural History of Innovation.New York:Riverhead Books,2010.
Jonas,G.The Circuit Riders:Rockefeller Money and the Rise of Modern Science. New York:W.W.Norton,1989.
Jones,D.S.“The Burden of Disease and the Changing Task of Medicine.”New England Journal of Medicine 366(June 21,2012):2333–38.
Jones,T.Detailing the Physician:Sales Promotion by Personal Contact with
the Medical and Allied Professions.New York:Romaine Pierson,1940.
Jonsen,A.R.The Birth of Bioethics. Oxford:Oxford University Press,1998.
Jordan,D.P.Napoleon and the Revolution. New York:Palgrave Macmillan,2012.
Jukes,T.H.“Some Historical Notes on Chlortetracycline.”Review of Infectious Diseases 7,no.5(September–October 1985):702–7.
Junod,S.W.“FDA and Clinical Drug Trials:A Short History.”Overviews of FDA History(September 7,2014).Retrieved July 4,2015.www.fda .gov/AboutFDA/WhatWeDo/History/Overviews/ucm304485.htm.
Kahn,E.J.All in a Century:The First Hundred Years of the Eli Lilly Company.Indianapolis:Eli Lilly,1976.
Kandel,E.The Age of Insight:The Quest to Understand the Unconscious in Art,Mind,and Brain,from Vienna 1900 to the Present. New York:Random House,2012.
Kardas,P.“Noncompliance in Current Antibiotic Practice.”Infectious Diseases in Clinical Practice 14,no.4(July 2006):s11–s14.
Keegan,J.The First World War. New York:Knopf,1998.
Kinch,M.,et al.“An Analysis of FDA -Approved Drugs for Infectious Disease:Antibacterial Agents.”Drug Discovery Today 19,no.9(September 2014):1283–87.
Koch,R.Essays of Robert Koch. Edited by K.C.Carter.New York:Greenwood Press,1987.
Kogan,H.The Long White Line:The Story of Abbott Laboratories. New York:
Random House,1963.
Kuehn,B.M.“Frances Kelsey Honored for FDA Legacy.”Journal of the American Medical Association 304,no.19(November 17,2010):2109–12.Laurence,W.L.“ ‘Wonder Drug’Aureomycin Found to Spur Growth 50%.”New York Times,April 10,1950,1.
Lawrence,C.“Joseph Lister.”In Oxford Dictionary of National Biography,edited by H.C.G.Matthew et al.Oxford:Oxford University Press,2004.Lax,E.The Mold in Dr.Florey’s Coat. New York:Henry Holt,2004.
Le Fanu,J.The Rise and Fall of Modern Medicine. New York:Little,Brown,1999.
Lear,J.“Taking the Miracle Out of the Miracle Drugs.”Saturday Review,January 3,1959,35–41.
Lear,J.“The Certification of Antibiotics.”Saturday Review,February 7,1959,43–48.
Lear,J.“SR Drug Reports and the United States Senate.”Saturday Review,December 12,1959,49–50.
Lear,J.“Public Health at 7 1/2 Per Cent.”Saturday Review,June 4,1960,37–41.
Lehmann,J.“Para -Aminosalicylic Acid in the Treatment of Tuberculosis.”Lancet 247,no.6384(January 1946):15–16.
Light,D.,et al.“Demythologizing the High Costs of Pharmaceutical Research.”BioSocieties 6(February 2011):34–50.
Lister,J.“Antiseptic Principle in the Practice of Surgery.”British Medical
Journal 2,no.5543(April 1967):9–12.
Lloyd,N.C.“Salvarsan —The First Chemotherapeutic Compound.”Chemistry in New Zealand 69,no.1(2005):24–27.
Loyd,E.“Aplastic Anemia Due to Chloramphenicol.”Antibiotics and Chemotherapy 2,no.1(January 1952):1–4.
Macfarlane,G.Howard Florey:The Making of a Great Scientist.Oxford:Oxford University Press,1979.
Macfarlane,G.Alexander Fleming:The Man and the Myth. Cambridge,MA:Harvard University Press,1984.
Macfarlane,G.“Howard Florey.”In Oxford Dictionary of National Biography,edited by H.C.G.Matthew et al.Oxford:Oxford University Press,2004.Maddison,A.The World Economy. Paris:Development Centre of the Organisation for Economic Co-operation and Development,2006.
Madison,J.A.Eli Lilly:A Life,1885–1997. Indianapolis:Indianapolis Historical Society,1989.
Maeder,T.Adverse Reactions. New York:William Morrow,1994.
Mahoney,T.The Merchants of Life:An Account of the American Pharmaceutical Industry. New York:Harper ＆Brothers,1958.
Maine Academy of Medicine and Science.“Therapeutics of a Country Doctor.”Journal of Medicine and Science 4,no.1(December 1897):284.
Major,R.T.“Selman Waksman—Scientist,Teacher,and Benefactor of Mankind.”Presentation Address for 1949 Research Award by the American Pharmaceutical Manufacturer’s Association,in Honor of Dr.Selman A.
Waksman.June 9,1949.Hot Springs,VA.
Margulis,L.,et al.What Is Life. New York:Simon ＆Schuster,1995.
Marks,H.M.“Making Risks Visible:The Science and Politics of Adverse Drug Reactions.In Ways of Regulating Drugs in the 19th and 20th Centuries, edited by J.P.Gaudilliere et al.Houndsmills,Basingstoke,UK:Palgrave Macmillan,2012,97–121.
Maurois,A.The Life of Alexander Fleming:Discoverer of Penicillin. London:Jonathan Cape,1959.
Mayo Clinic.“Mayo Clinic Information:History”(2001–2015).Mayo Clinic.Retrieved March 17,2015.www.mayoclinic.org/careerawareness /mi-history.html.
McEvilla,J.D.Competition in the American Pharmaceutical Industry.Pittsburgh:University of Pittsburgh,1955.
McFadyen,R.“Thalidomide in America:A Brush with Tragedy.Clio Medica 11,no.2(July 1976):79–93.
McKelvey,M.Evolutionary Innovations:The Business of Biotechnology. New York:Oxford University Press,1996.
McLaren,A.Impotence:A Cultural History. Chicago:University of Chicago Press,2007.
Merck,G.W.“The Chemical Industry and Medicine.”Industrial and Engineering Chemistry 27,no.7(July 1,1935):739–41.
Merck,G.W.“Biological Warfare:Report to the Secretary of War by Mr.George W.Merck,Special Consultant for Biological Warfare”(January 3,1946).Washington,DC:War Department Bureau of Public Relations,1946.
Meynell,E.“Some Account of the British Military Hospitals of World War I at Etaples,in the Orbit of Sir Almroth Wright.”Journal of the Army Medical Corps 142(1996):43–47.
Miller,G.H.“Abrupt Onset of the Little Ice Age Triggered by Volcanism and Sustained by Sea-Ice/Ocean Feedbacks.”Geophysical Research Letters 39(January 31,2012).
Miller,T.S.“Byzantine Hospitals.”Dumbarton Oaks Papers 38(1984).Mintz,M.“‘Heroine’of FDA Keeps Bad Drug Off Market.”Washington Post,July 15,1962,1.
Moberg,C.L.“Penicillin’s Forgotten Man:Norman Heatley.”Science 253,no.5021(August 19,1991):734–35.
Moskowitz,M.“Wonder Profits in Wonder Drugs.”The Nation,April 27,1957,357–60.
MRC.“Treatment of Pulmonary Tuberculosis with PAS and Streptomycin:A Preliminary Report.”British Medical Journal(December 31,1949):1521.National Academies.“Articles of Organization of the National Research Council”(June 15,2007).National Academies.Retrieved June 4,2015.www.nationalacademies.org/nrc/na_070358.html.
Nelson,K.E.“Early History of Infectious Disease.”In K.E.Nelson,Infectious Disease Epidemiology, 3rd ed.Burlington,MA:Jones and Bartlett,2014,1–21.
Neushul,P.“Science,Government,and the Mass Production of Penicillin.”Journal of the History of Medicine and Allied Sciences 48,no.4(October 1993):371–95.
New Scientist.“Some Bacteria Choose to Live in a Pool of Penicillin.”New Scientist,June 8,1972,546.
New York Times.“The New Hope for Tuberculosis:Discovery of ‘Opsonins’Promises to Revolutionize Medicine.”New York Times,March 31,1907,1.New York Times.“Near End of Chase for Deadly Elixir:Government Agents Hope to Recover Today the Last of 700 Bottles.”New York Times,October 25,1937.
Nobel Prize Foundation.“The Nobel Prize in Chemistry 1965”(2014).NobelPrize.org.Retrieved April 30,2015.www.nobelprize.org/nobel _prizes/chemistry/laureates/1965/.
North,E.,et al.“Observations on the Sensitivity of Staphylococci to Penicillin.”Medical Journal of Australia 2(1945):44–46.
O’Neill,L.A.“Immunity’s Early-Warning System.”Scientific American,January 2005.
Osler,W.S.The Principles and Practice of Medicine,Designed for the Use of Practitioners and Students of Medicine. New York:Appleton,1923.
Paget,S.Pasteur and After Pasteur. London:A＆C Black,1914.
Parke,Davis ＆Company.Therapeutic Notes, Vol.1.Detroit:Parke,Davis ＆Company,1894.
Payne,D.J.“Drugs for Bad Bugs:Confronting the Challenges of Antibacterial Discovery.”Nature Reviews—Drug Discovery 6,no.1(January 2007):29–42.
Peterson,A.F.Pharmaceutical Selling,“Detailing,”and Sales Training,2nd ed.Scarsdale,NY:Heathcote-Woodbridge,1959.
Podolsky,S.H.The Antibiotic Era:Reform,Resistance,and the Pursuit of a Rational Therapeutics. Baltimore,MD:Johns Hopkins University Press,2015.
Porter,E.“A Dearth of Innovation for Key Drugs.”New York Times,July 23,2014,B1.
Pringle,P.Experiment Eleven:Dark Secrets Behind the Discovery of a Wonder Drug. New York:Walker ＆Co.,2012.
Raoult,D.,et al.“The History of Epidemic Typhus.”Infectious Disease Clinics in North America 18,no.1(March 2004):127–40.
Rasmussen,N.“The Moral Economy of the Drug Company -Medical Scientist Collaboration in Interwar America.”Social Studies of Science 34(2004):161–85.
Rasmussen,N.“The Drug Industry and Clinical Research in Interwar America:Three Types of Physician Collaborator.”Bulletin of the History of Medicine 79(2005):50–80.
Ravina,E.The Evolution of Drug Discovery:From Traditional Medicines to Modern Drugs. New York:John Wiley ＆Sons,2011.
Reichl,R.“The F.D.A.’s Blatant Failure on Food.”New York Times,July 30,2014.
Reilly,G.W.The FDA and Plan B:The Legislative History of the Durham --Humphrey Amendments and the Consideration of Social Harms in the Rx-OTC Switch(May 12,2006).LEDA at Harvard Law School.Retrieved June 28,2015.dash.harvard.edu/bitstream/handle/1/8965550/Reilly06.html?sequence=2.
Richards,A.“Production of Penicillin in the United States(1941–1946).”Nature 201(February 1964):441–45.
Richards,A.N.“Remarks Concerning the Relations Between Universities,Industry and Government with Respect to Medical Research.”The Clinical Problems of Advancing Years(March 16,1949).
Riethmiller,S.“Ehrlich,Bertheim,and Atoxyl:The Origins of Modern Chemotherapy.”Bulletin of the History of Chemistry 23(1999):28–33.
Robbins,L.Louis Pasteur and the Hidden World of Microbes. Oxford:Oxford University Press,2001.
Rodengen,J.L.The Legend of Pfizer. Fort Lauderdale,FL:Write Stuff Syndicate,1999.
Rolleston,J.“Venereal Disease in Literature.”British Journal of Venereal Disease 10,no.3(1934):147–74.
Roosevelt,F.D.Executive Order 8807 Establishing the Office of Scientific Research and Development(June 28,1941).The American Presidency Project.Retrieved December 14,2014.www.presidency.ucsb.edu/ws/index.php?pid=16137#.
Root-Bernstein,R.S.“How Scientists Really Think.”Perspectives in Biology
and Medicine 32,no.4(Summer 1987):473–89.
Root-Bernstein,R.S.Discovering:Inventing and Solving Problems at the Frontiers of Scientific Knowledge. Cambridge,MA:Harvard University Press,1989.
Rosen,W.The Most Powerful Idea in the World:A Story of Steam,Industry,and Invention. New York:Random House,2010.
Rosenberg,C.E.“The Therapeutic Revolution:Medicine,Meaning and Social Change in Nineteenth Century America.”Perspectives in Biology and Medicine 20,no.4(Summer 1977):485–506.
Roth,K.H.Development and Production of Synthetic Gasoline. Translated by Nicholas Levis.I.G.Farbenindustrie AG in World War II(2011).Retrieved March 8,2015.www.wollheim -memorial.de/en/entwicklung_und_produktion_von_synthetischem_benzin.
Rothman,S.The Pursuit of Perfection:The Promise and Perils of Medical Enhancement. New York:Vintage Books,2004.
Rothman,S.M.Living in the Shadow of Death:Tuberculosis and the Social Experience of Illness in American History, 1st ed.Baltimore,MD:Johns Hopkins University Press,1995.
Roy,A.,et al.“Effect of BCG Vaccination Against Mycobacterium tuberculosis Infection in Children:Systematic Review and Meta-analysis.British Medical Journal 349,no.g4643(August 2014):1–11.
Sarrett,L.H.Max Tishler 1906–1989:A Biographical Memoir. Washington,DC:National Academies Press,1995.
Saturday Review.Letters to the Editor.Saturday Review,January 24,1959,21–23.
Schatz,A.“The True Story of the Discovery of Streptomycin.”Actinomycetes 4,no.2(August 1993):27–39.
Seppa,N.“Low-Tech Bacteria Battle.”Science News,October 4,2014,22–26.Sexton,P.Legends of Literature:The Best Articles,Interviews,and Essays from the Archives of Writer’s Digest Magazine. New York:Writer’s Digest Books,2007.
Shaw,G.The Doctor’s Dilemma,Getting Married,＆the Shewing-Up of Blanco Posnet. London:Constable ＆Co.,1947.
Sheehan,J.,et al.“The Fire That Made Penicillin Famous.”Yankee Magazine,November 1982,125–203.
Silberman,C.E.“Drugs:The Pace Is Getting Furious.”Forbes,May 1960,140.
Silcox,H.“Production of Penicillin.”Chemical Engineering News 24,no.20(October 1946):2762–64.
Silverman,M.,et al.Pills,Profits,and Politics. Berkeley:University of California Press,1974.
Smith,I.Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence.Clinical Microbiology Reviews 16,no.3(July 2003):463–96.
Smith,M.Overview of Benzene -Induced Aplastic Anaemia.European Journal of Haemotology—Supplementum 60(1996):107–10.
Starr,P.The Social Transformation of American Medicine:The Rise of a Sovereign Profession and the Making of a Vast Industry. New York:Basic Books,1984.
Steen,K.The American Synthetic Organic Chemicals Industry:War and Politics,1910–1930. Charlotte:University of North Carolina Press,2014.Stephens,T.,et al.Dark Remedy:The Impact of Thalidomide and Its Revival as a Vital Medicine. New York:Basic Books,2001.
Stevenson,W.“Charles Pfizer.”In W.J.Hausman,Immigrant Entrepreneurship:German American Business Biographies 1720 to the Present, Vol.2.Washington,DC:German Historical Institute,2014.
Swann,J.P.Academic Scientists and the Pharmaceutical Industry.
Baltimore,MD:Johns Hopkins University Press,1988.
Swann,J.P.“FDA and the Practice of Pharmacy:Prescription Drug Regulation Before the Durham -Humphrey Amendment of 1951.”Pharmacy in History 36,no.2(1994):55–70.
Tager,M.“John F.Fulton,Coccidioidomycosis,and Penicillin.”Yale Journal of Biology and Medicine 49(June 1976):391–98.
Temin,P.Taking Your Medicine:Drug Regulation in the United States.Cambridge,MA:Harvard University Press,1980.
Thagard,P.“The Concept of Disease:Structure and Change.”Communication and Cognition 29(1996):445–78.
Thomas,L.The Youngest Science:Notes of a Medicine Watcher. New York:Viking,1983.
Tillitt,M.H.“Army-Navy Pay Tops Most Civilians’Unmarried Private’s Income Equivalent to $3,600 Salary.”Barron’s National Business and Financial Weekly,April 24,1944.
Tishler,M.Interview with Max Tishler.By L.G.Heitzman.November 14,1983.Philadelphia:Chemical Heritage Society.
Tocqueville,A.de.Reflections:The Revolutions of 1848. New Brunswick,NJ:Transaction Publishers,1987.
Todar,K.“Mycobacterium tuberculosis and Tuberculosis.”Todar’s Online Textbook of Bacteriology(2008–2012).Retrieved March 13,2015.textbookofbacteriology.net/tuberculosis_3.html.
Todd,A.,et al.Perspectives in Organic Chemistry. New York:Interscience Publishers,1956.
University of Pennsylvania.“Penicillin and the American Public.”Health,Medicine,and American Culture 1930–1960(2002).Retrieved March 6,2015.ccat.sas.upenn.edu/goldenage/state/pub/sl_pub1.htm.
University of Pennsylvania.“Personal Correspondence:Penicillin.”Health,Medicine,and American Culture 1930–1960(2002).Retrieved March 6,2015.ccat.sas.upenn.edu/goldenage/state/pub/letters/sl_pub_letters_index.htm.
Van de Vijver,G.,et al.The Pre-Psychoanalytic Writings of Sigmund Freud.London:Karnac Books,2002.
Van den Belt,H.Spirochaetes,Serology,and Salvarsan:Ludwig Fleck and the Construction of Medical Knowledge About Syphilis. Wageningen,
Netherlands:Grafisch bedrijf Ponsen ＆Looijen b.v.,1997.
Volansky,R.“Paul Ehrlich:The Man Behind the‘Magic Bullet.’”HemOnc Today(May 25,2009).
Waksman,S.A.U.S.Streptomycin and the Process of Preparation,Patent No.2,449,866,September 21,1948.
Waksman,S.A.The Conquest of Tuberculosis. Berkeley:University of California Press,1964.
Waksman,S.A.The Antibiotic Era:A History of the Antibiotics and of Their Role in the Conquest of Infectious Diseases and in Other Fields of Human Endeavor. Tokyo:Selman Foundation of Japan,1975.
Waller,J.Leaps in the Dark:The Making of Scientific Reputations. Oxford:Oxford University Press,2004.
Weidel,W.,et al.“Bagshaped Macromolecules—A New Outlook on Bacterial Cell Walls.”In F.Nord,Advances in Enzymology and Related Areas of Molecular Biology, Vol.26.New York:John Wiley ＆Sons,2009,193–223.
Wirth,T.,et al.“Origin,Spread and Demography of the Mycobacterium tuberculosis Complex.”PLoS Pathogens 4,no.9(September 2008):1–10.Witkop,B.“Paul Ehrlich and His Magic Bullets—Revisited.”Proceedings of the American Philosophical Society 143,no.4(December 1999):540–57.
Woese,C.R.“Bacterial Evolution.”Microbiological Reviews 55,no.2(1987):221–71.
Woodward,R.“The Total Synthesis of Vitamin B12.”Pure and Applied
Chemistry 33,no.1(January 1973):145–78.
Woytinsky,E.,et al.World Population and Production:Trends and Outlook.New York:Twentieth Century Fund,1953.
Xue,K.“Superbug:An Epidemic Begins.”Harvard Magazine,May–June 2014,40–49.
Younkin,P.A.Making the Market:How the American Pharmaceutical Industry Transformed Itself During the 1940s. Berkeley,CA:Institute for Research on Labor and Economics,March 2008.
Younkin,P.A.“A Healthy Business:The Evolution of the U.S.Market for Prescription Drugs.”PhD diss.,University of California,Berkeley,2010.
Zachary,G.P.Endless Frontier:Vannevar Bush,Engineer of the Ameri can Century. New York:The Free Press,1997.
Zimmer,C.“We May Be Our Own Best Medicine.”New York Times,September 16,2014,D7.